Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

ClinicalTrials.gov ID: NCT05579366

Public ClinicalTrials.gov record NCT05579366. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable).

Study identification

NCT ID
NCT05579366
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Genmab
Industry
Enrollment
884 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2022
Primary completion
Jun 30, 2027
Completion
Sep 30, 2027
Last update posted
Aug 3, 2026

2022 – 2027

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
USOR HonorHealth Phoenix Arizona 85016 Recruiting
USOR Arizona Oncology Associates Tucson Arizona 85711 Recruiting
University of California Los Angeles Medical Center Los Angeles California 90095 Recruiting
University of California, San Diego; Moores Cancer Center San Diego California 92093 Recruiting
USOR Sansum Clinic Santa Barbara California 93105 Recruiting
Providence Medical Foundation Santa Rosa California 95403 Recruiting
USOR Florida Cancer Specialists South Fort Myers Florida 33908 Recruiting
USOR Florida Cancer Specialists North St. Petersburg Florida 33709 Recruiting
USOR Florida Cancer Specialists East West Palm Beach Florida 33401 Recruiting
Augusta University Georgia Cancer Center Augusta Georgia 30912 Recruiting
University of Kansas Medical Center (KUMC) Westwood Kansas 66205 Recruiting
USOR Maryland Oncology Hematology Rockville Maryland 20850 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Dana Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Karmanos Cancer Institute Detroit Michigan 48085 Recruiting
START Midwest Grand Rapids Michigan 49503 Recruiting
USOR Minnesota Oncology Hematology Maplewood Minnesota 55109 Recruiting
MD Anderson Cancer Center at Cooper- Two Cooper Plaza Camden New Jersey 08103 Recruiting
Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 Recruiting
University of Oklahoma - Health Sciences Center Oklahoma City Oklahoma 73104 Recruiting
USOR Oncology Associates of Oregon, P.C. Eugene Oregon 97401 Recruiting
Compass Oncology - Rose Quarter Portland Oregon 97227 Recruiting
USOR Alliance Cancer Specialist Doylestown Pennsylvania 18901 Recruiting
Allegheny Health Network Pittsburgh Pennsylvania 15224 Recruiting
Women and Infants Hospital of Rhode Island Providence Rhode Island 02905 Recruiting
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
USOR Texas Oncology Abilene Texas 79606 Recruiting
Texas Oncology - Central / South Texas Austin Texas 78758 Recruiting
Mary Crowley Cancer Research Dallas Texas 75521 Recruiting
USOR Texas Oncology Fort Worth Texas 76104 Recruiting
Texas Oncology - Northeast TX Tyler Texas 75702 Recruiting
USOR Texas Oncology Gulf Coast Woodland Texas 77380 Recruiting
START Mountain Region West Valley City Utah 84119 Recruiting
USOR Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting
USOR Virginia Oncology Associates Norfolk Virginia 23502 Recruiting
Swedish Cancer Institute Seattle Washington 98104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05579366, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05579366 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →